Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
glycopyrrolate
glycopyrrolate
Brand names: glycopyrronium, Robinul, Seebri Neohaler
| Form | Strength |
|---|---|
| CAPSULE, INHALATION | 15.6 mcg |
| SOLUTION, INJECTABLE | 0.2 mg/mL |
| TABLET, ORAL | 1 mg; 2 mg |
Last updated: Mar. 31, 2022
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
Glycopyrrolate bromide DPI (Seebri Neohaler) is a Non-Formulary agent. All orders will be automatically changed to Tiotropium (SPIRIVA Respimat). See Therapeutic Interchange.